The NSQs reported by the states during the month include drugs labelled as manufactured by public sector firm Hindustan Antibiotics Ltd, and private manufacturers such as Cipla, Franco-Indian ...

Alzheimer’s Therapeutics MarketThe global Alzheimer’s therapeutics market is projected to experience significant growth, with an expected valuation of USD 3,052.3 million in 2023. The market is ...

Zydus Lifesciences Limited (Formerly known as Cadila Healthcare Limited) is one of the leading innovation driven pharmaceutical companies in India with presence across the pharmaceutical value ...

Anti-Fungal Therapy Market. The global anti-fungal therapy market is set to experience significant growth, with a projected ...

Zydus Lifesciences Ltd. key Products/Revenue Segments include Pharmaceutical Products ... As on 31-12-2024, the company has a total of 100.62 Crore shares outstanding.Cadila Healthcare Share Price ...

What does Nifty Pharma represent? Tracks the performance of pharmaceutical companies in India, comprising leading pharmaceutical stocks listed on the National Stock Exchange (NSE), reflecting trends ...

AstraZeneca is asking a court to immediately stop generic drugmakers from their plans to make and sell generic forms of ...

President Trump on Friday vowed to impose sweeping tariffs on semiconductor chips, pharmaceuticals, steel and aluminum and oil and gas. “We’ll be doing pharmaceuticals. Importantly in drugs ...

The "Antibiotic Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering.Antibiotic Collaboration and Licensing Deals provides a comprehensive ...

Founded in 1935 by Khwaja Abdul Ahmeid, Cipla operates through two segments: Pharmaceuticals and New Ventures. Cipla Limited specialises in developing medications, primarily treating respiratory ...

In addition, Collegium Pharmaceuticals increased the list price of pain relief drug Nucynta by 15% and Pfizer upped the price of aplastic anemia treatment Atgam by 15%. While Novartis increased ...